Popp, Albrecht Werner
Varathan, Nadshathra
Buffat, Helene
Senn, Christoph
Perrelet, Romain
Lippuner, Kurt
Article History
Received: 11 November 2017
Accepted: 16 January 2018
First Online: 29 January 2018
Compliance with Ethical Standards
:
: Kurt Lippuner is a primary investigator in clinical development programs in the field of osteoporosis from Amgen. Albrecht Popp and Christoph Senn are Sub-Investigators in clinical development programs in the field of osteoporosis from Amgen, Albrecht Popp has received personal fees for participation in advisory board meetings from Amgen Switzerland and Labatech Pharma. Nadshathra Varathan and Romain Perrelet declare that they have no conflict of interest.
: This study was approved by the cantonal ethical review committee of Bern, Switzerland. All participants have provided their written informed consent. The study was carried out in accordance with the principles enunciated in the current version of the Declaration of Helsinki (DoH), the Essentials of Good Epidemiological Practice issued by Public Health Schweiz (EGEP), the Swiss Law and Swiss regulatory authority’s requirements as applicable.